Cytek Biosciences, Inc. (CTKB) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

15/25

Growth 4 Margin 2 Expansion 5 Platform 2 Financial 2

latest quarter score

Earnings Reports

15
Scitech Biosciences (CTKB) Q2 2026: U.S. Revenue Jumps 18% as Installed Base Expansion Drives Recurring Growth
August 06, 2026
14
Scitech Biosciences (CTKB) Q1 2026: Recurring Revenue Jumps 19%, Anchoring Business Model Shift
May 08, 2026
14
Scitech Biosciences (CTKB) Q4 2025: Recurring Revenue Jumps 21% as Installed Base Expands
February 27, 2026
12
SciTech Biosciences (CTKB) Q3 2025: EMEA Revenue Down 28% as APAC and Recurring Lines Offset Regional Weakness
November 06, 2025
18
CTKB Q2 2025: Recurring Revenue Jumps 16% as Installed Base Hits 3,295 Units
August 06, 2025
22
Scitech Biosciences (CTKB) Q1 2025: Recurring Revenue Rises to 31% Amid 7.6% Top-Line Decline
July 05, 2025
Cytek Biosciences (CTKB) Q4 2024: Adjusted EBITDA Surges 77% Amid 8.5% Instrument Unit Growth
February 27, 2025

Browse all companies